Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral acetazolamide for X-linked retinoschisis
ACTRN12610000476033Phase 2Not yet recruiting
- Sponsor
- The University of Sydney
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetazolamide in X-linked retinoschisis (XLRS), sponsored by The University of Sydney. Primary endpoints: Best corrected visual acuity using Snellen and LogMAR chart and Retinal thickness by optical coherence tomography. Planned start Jun 2010; status: not yet recruiting.
02
Drugs
acetazolamide
03
Conditions
X-linked retinoschisis (XLRS)
Beyond the preview
Go deeper on ACTRN12610000476033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000476033.